Immunotherapy for NAFLD and NAFLD-related hepatocellular carcinoma
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Endocrinology"
DOI: 10.3389/fendo.2023.1150360
Abstract: The progression of non-alcoholic fatty liver disease (NAFLD), the most common liver disease, leads to non-alcoholic steatohepatitis and hepatocellular carcinoma. Despite the increasing incidence and prevalence of NAFLD, its therapeutic and preventive strategies to lower… read more here.
Keywords: related hepatocellular; hepatocellular carcinoma; immunotherapy nafld; nafld related ... See more keywords
Targeting T Cell Subtypes for NAFLD and NAFLD-Related HCC Treatment: An Opinion
Sign Up to like & getrecommendations! Published in 2021 at "Frontiers in Medicine"
DOI: 10.3389/fmed.2021.789859
Abstract: The increasing prevalence of non-alcoholic fatty liver disease (NAFLD), as well as its advanced stage non-alcoholic steatohepatitis (NASH) with the progression of liver inflammation and cell death with or without hepatic fibrosis, brings a heavy… read more here.
Keywords: nafld nafld; liver disease; nafld related; treatment ... See more keywords